Astrana Health (NASDAQ:ASTH) Reaches New 52-Week High – Here’s Why

Astrana Health, Inc. (NASDAQ:ASTH)’s share price hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $44.99 and last traded at $44.5560, with a volume of 4113 shares traded. The stock had previously closed at $44.51.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Zacks Research upgraded shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. TD Cowen increased their target price on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Barclays raised Astrana Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $37.00 to $50.00 in a report on Tuesday, May 26th. Needham & Company LLC boosted their price target on Astrana Health from $30.00 to $41.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Finally, BTIG Research reaffirmed a “buy” rating and set a $50.00 price objective on shares of Astrana Health in a research note on Tuesday, June 2nd. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, Astrana Health presently has an average rating of “Moderate Buy” and a consensus target price of $45.00.

Astrana Health Trading Up 0.1%

The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.35 and a current ratio of 1.35. The stock has a market capitalization of $2.48 billion, a PE ratio of 73.00 and a beta of 1.00. The business’s 50-day moving average is $37.46 and its two-hundred day moving average is $28.79.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.74 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company had revenue of $965.10 million during the quarter, compared to the consensus estimate of $949.21 million. During the same quarter in the prior year, the firm earned $0.42 EPS. Astrana Health’s quarterly revenue was up 55.6% on a year-over-year basis. As a group, equities research analysts anticipate that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ASTH. Signaturefd LLC boosted its holdings in Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares in the last quarter. GAMMA Investing LLC increased its position in Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares during the period. Strs Ohio purchased a new position in shares of Astrana Health during the 4th quarter worth approximately $40,000. Tower Research Capital LLC TRC raised its stake in shares of Astrana Health by 323.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after buying an additional 3,517 shares in the last quarter. Finally, State of Wyoming acquired a new stake in shares of Astrana Health in the 2nd quarter valued at approximately $132,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.